FLEMINGTON, N.J.--(BUSINESS WIRE)--Nov. 22, 2005--NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company with an oral spray technology applicable to a broad range of therapeutic areas and product categories, announced that board of directors member, and non-executive Chairman of the Board, Robert G. Savage has announced his intention not to stand for re-election to NovaDel’s board at the company’s 2006 annual meeting of shareholders. Mr. Savage has served as a director of the company since 2004. “During my tenure at NovaDel, the Company has been transformed in a number of ways, including our bringing on board a highly qualified Chief Operating Officer/Chief Executive Officer designee, to lead the management team going forward. I believe the organization’s accomplishments have been significant,” said Mr. Savage.
